Muhammad Adeeb Khan, Abida Raza, M. Ovais
Feb 5, 2018
Citations
0
Influential Citations
19
Citations
Quality indicators
Journal
International Journal of Polymeric Materials and Polymeric Biomaterials
Abstract
ABSTRACT Sorafenib is the only approved targeted agent against hepatocellular carcinoma (HCC). It has several limitations predominantly poor aqueous solubility and hepatic first-pass effect that limits its oral delivery leading to low bioavailability, large inter-subject variability, narrow therapeutic window and side effects. Tosylate is used to improve its solubility, which is practically insoluble in water (60 µg/mL) so problems with sorafenib solubility persist. To improve the paharmacokinetic profile, minimize the side effects, and targeting drug to the tumor tissues, several polymeric nano-formulations are being evaluated. In this comprehensive review, various reported polymeric nano-delivery systems for sorafenib are comprehensively covered. GRAPHICAL ABSTRACT